Skip to Main Content

Paper Details

PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer.
J Clin Invest
214
2019
Author NameAffiliation
Andrew Lamb
Alan AshworthUCSF Helen Diller Family Comprehensive Cancer Center
Syed HaiderThe Breast Cancer Now Toby Robins Breast Cancer Research Centre and.
  • 1 - 3

Datasets

Release 1.2